OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
14
Results
Show all
Save search
Copy query
Show results for
Unknown
(14)
Release Date
2025
(2)
2024
(2)
2020
(2)
2017
(2)
2016
(2)
2015
(2)
2018
(1)
2013
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Cabozantinib in progressive medullary thyroid cancer.
Not available
S-EPMC4164813
|
biostudies-literature
Cite
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.
Not available
S-EPMC5105166
|
biostudies-literature
Cite
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.
Not available
S-EPMC5643159
|
biostudies-literature
Cite
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.
Not available
S-EPMC6002769
|
biostudies-literature
Cite
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Not available
S-EPMC5612337
|
biostudies-literature
Cite
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Not available
S-EPMC4445140
|
biostudies-literature
Cite
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.
Not available
S-EPMC4478717
|
biostudies-literature
Cite
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial.
Not available
S-EPMC11658795
|
biostudies-literature
Cite
Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial.
Not available
S-EPMC11919559
|
biostudies-literature
Cite
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets